Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MTAB-7745

ABSTRACT: RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor (24h treatment)

PROVIDER: E-MTAB-7745 | ExpressionAtlas | 2019-08-05

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Similar Datasets

RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor (24h treatment)

Project description:RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor (24h treatment)

| PRJEB31557 | ENA

RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor

Project description:RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor

| PRJEB26484 | ENA

RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor

Project description:To identify the genes regulated by the Glucocorticoid Receptor (GR), we performed RNA-seq in GR18 cell line (derived from U2OS ATTC:HTB-96, stably transfected with an expression construct for GR), upon glucocorticoid (dexamethasone) or vehicle (ethanol) treatment.

2018-10-29 | E-MTAB-6738 | biostudies-arrayexpress

E-MTAB-6738

Project description:RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor

2019-01-16 | E-MTAB-6738 | ExpressionAtlas

RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor (24h treatment)

2019-03-11 | E-MTAB-7745 | biostudies-arrayexpress

Glucocorticoid receptor gene expression profiling (BeadArray) in IMR90 cell line

Project description:To identify the sequences responsible for recruitment of Glucocorticoid receptor (GR) to individual loci, we performed BeadArray gene expression analysis in IMR90 cell line (ATTC:CCL-186), upon glucocorticoid treatment.

2015-02-25 | E-MTAB-2954 | biostudies-arrayexpress

RNA-seq in the U2OS-AR cell line to identify genes regulated by the androgen receptor

Project description:RNA-seq in the U2OS-AR cell line to identify genes regulated by the androgen receptor

| PRJEB40608 | ENA

BioID Assay of BirA*-hARGLU1 or BirA*-hGR in Flp-In T-Rex 293 cells

Project description:ARGLU1 is a Transcriptional Coactivator and Splicing Regulator Important for Stress Hormone Signaling and Development Stress hormones bind and activate the glucocorticoid receptor (GR) in many tissues including the brain. We identified arginine and glutamate rich 1 (ARGLU1) in a screen for new modulators of glucocorticoid signaling in the CNS. Biochemical studies show that the glutamate rich C-terminus of ARGLU1 coactivates multiple nuclear receptors including the glucocorticoid receptor (GR) and the arginine rich N-terminus interacts with splicing factors and binds to RNA. RNA-seq of neuronal cells depleted of ARGLU1 revealed significant changes in the expression and alternative splicing of distinct genes involved in neurogenesis. Loss of ARGLU1 is embryonic lethal in mice, and knockdown in zebrafish causes neurodevelopmental and heart defects. Treatment with dexamethasone, a GR activator, also induces changes in the pattern of alternatively spliced genes, many of which were lost when ARGLU1 was absent. Importantly, the genes found to be alternatively spliced in response to glucocorticoid treatment were distinct from those under transcriptional control by GR, suggesting an additional mechanism of glucocorticoid action is present in neuronal cells. Our results thus show that ARGLU1 is a novel factor for embryonic development that modulates basal transcription and alternative splicing in neuronal cells with consequences for glucocorticoid signaling.

2019-02-15 | PXD012555 | Pride

ARGLU1 RIME experiment in N2a cells

2019-02-15 | PXD012406 | Pride

Expression of DND41 cell lines treated with 1M-BM-5M Dexamethasone for 24h after shPTEN infection

Project description:Glucocorticoid resistance is a major driver of therapeutic failure in T-cell acute lymphoblastic leukemia (T-ALL). Here we identify the AKT1 kinase as a signaling factor driving glucocorticoid resistance in T-ALL. Mechanistically, AKT1 directly phosphorylates the glucocorticoid receptor NR3C1 protein and blocks glucocorticoid-induced NR3C1 transcription by inhibiting glucocorticoid-induced NT3C1 translocation to the nucleus. Consistently, pharmacologic inhibition of AKT1 increases the response of T-ALL cells to glucocorticoid therapy and effectively reverses glucocorticoid resistance in vitro and in vivo. These results warrant the clinical testing of AKT1 inhibitors and glucocorticoids in combination for the treatment of T-ALL. Gene Expression Analysis of DND41 cell lines infected with shPTEN or shLUC and treated with 1M-BM-5M Dexamethasone vs DMSO for 24h, in triplicate.

2013-10-01 | E-GEOD-41062 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data